Family intervention for Black teens with type 1 diabetes
Official title: Family mHealth Intervention to Improve Health Outcomes in Black Youth With Type 1 Diabetes
Run by Wayne State University · NCT06275412 · Data updated 2026-11-12
This study is testing a new mobile health program to see if it can help Black teens with type 1 diabetes manage their blood sugar better and improve their family relationships.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 10 Years to 14 Years |
| Sex | All |
| Enrollment | 216 (estimated) |
| Sponsor | Wayne State University Academic / other |
| Locations | 4 sites (Washington D.C., District of Columbia and 3 other locations) |
| Status | Recruiting |
| Started | September 16, 2024 |
| Main results expected | April 30, 2028 |
| Study ends | April 30, 2028 |
| Registry record updated | August 27, 2026 |
| Trial ID | NCT06275412 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are Black adolescents aged 10 to 14 years diagnosed with type 1 diabetes for at least six months, along with their willing primary caregivers.
✕Probably not a fit
Patients with mental health conditions that could affect data integrity or those with co-morbid conditions affecting diabetes management may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the effectiveness of The 3Ms 2.0 intervention, delivered via mobile health technology, in improving glycemic control and family relationships among Black adolescents with type 1 diabetes and their primary caregivers. It is a multicenter, randomized controlled trial involving 216 adolescent-caregiver dyads, who will be assigned to either the intervention group or an educational control group. The intervention consists of three brief sessions aimed at enhancing parental supervision of diabetes management, while the control group receives general diabetes education. The trial is conducted at two sites, with Wayne State University overseeing the management.
Why it matters
Potential benefit: If successful, this intervention could lead to improved diabetes management and reduced caregiver distress for Black adolescents with type 1 diabetes.
How similar studies have gone: Other studies have shown promise in family-based interventions for diabetes management, suggesting potential success for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age: 10 years, 0 months - 14 years, 11 months * Diagnosed with Type 1 diabetes * Diagnosed for at least 6 months * Black * Primary caregiver willing to participate * Residence within 30 miles of a recruitment site * Caregiver ownership of an Internet-enabled device (cell phone, laptop or desktop computer, tablet, etc) Exclusion Criteria: * Mental health conditions that might compromise data integrity (e.g., developmental delay, schizophrenia, psychosis, current suicidality, homicidality) * Co-morbid medical condition resulting in atypical diabetes management (e.g., cystic fibrosis) * Inability to speak or read English * Child is in out-of-home placement
Where it's running
-
Children's National Hospital
Washington D.C., District of Columbia, United States Recruiting -
Wayne Pediatrics
Detroit, Michigan, United States Recruiting -
LeBonheur Children's Hospital
Memphis, Tennessee, United States Recruiting -
University of Tennessee Health Science Center-Memphis
Memphis, Tennessee, United States Recruiting
Study contacts
- Principal investigator: Deborah A Ellis, Ph.D. — Wayne State University
- Study coordinator: Deborah A Ellis, Ph.D.
- Email: dellis@med.wayne.edu
- Phone: 313-577-1055
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Semaglutide on body composition in adults with type 1 diabetes and overweight/obesity
This study tests whether weekly semaglutide changes body composition in adults with type 1 diabetes who are overweight or obese, compared with a placebo over 24 weeks.
-
Next Generation Extended Wear Sensors in Type 1 and Type 2 Diabetes
This study tests a new extended wear sensor and algorithm in people with type 1 or type 2 diabetes to see how well it works across adults and children.
-
CGM-guided carb awareness education for adults with Type 1 diabetes
This study tests whether teaching mealtime insulin dosing using CGM data helps adults with Type 1 diabetes who don’t usually count carbs.
-
Safety and effectiveness of GLP-1 receptor agonists and SGLT inhibitors added to insulin in adults with type 1 diabetes
This registry will see if adding GLP-1RA or SGLTi therapies to insulin helps adults with type 1 diabetes over one year.
-
Think-Find-Solve activities for insulin self-management in children with type 1 diabetes
A behavior-change activity book is tested with children aged 8–12 with type 1 diabetes and their parents to see if it improves daily insulin self-management.
-
Near-sensor insulin delivery with CGM in people with type 1 diabetes
A small early-feasibility study tests a dual-port insulin patch pump that includes a CGM sensor to see if delivering insulin near the sensor affects glucose readings and whether an automated control algorithm can manage glucose.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.